Trial
NCT00635076
A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Panic Disorder
Intervention
placebo
Why stopped
Please see Detailed Description for the termination reason.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-28